In the 786-0 tumour xenografts, Western blot analysis revealed a significant decrease (66 and a 33 %, p < 0.05) in the level of phosphorylated AKT and PRAS40, respectively, in the AZD8186-treated group compared to vehicle (Fig. 4a). The gene discussed is AKT1S1; the disease is neoplasm.